Darzalex

Johnson & Johnson nabs another combo approval for myeloma star Darzalex
Johnson & Johnson nabs another combo approval for myeloma star Darzalex
Fierce Pharma
JNJ
Multiple Myeloma
Darzalex
Flag link:
3 Big Pharma Companies With the Best Pipelines
3 Big Pharma Companies With the Best Pipelines
Motley Fool
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
Flag link:
Looking for Darzalex sales expansion, J&J, Genmab hit a wall in lymphoma
Looking for Darzalex sales expansion, J&J, Genmab hit a wall in lymphoma
Fierce Pharma
Darzalex
JNJ
Genmab
non-Hodgkin's lymphoma
Flag link:
J&J pulls the plug on PhII study for NHL after Darzalex falls short
J&J pulls the plug on PhII study for NHL after Darzalex falls short
Endpoints
JNJ
clinical trials
Darzalex
Flag link:
4 Reasons Johnson & Johnson Surged 8% in February
4 Reasons Johnson & Johnson Surged 8% in February
Motley Fool
JNJ
Darzalex
Actelion
Donald Trump
Flag link:
Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand
Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand
Motley Fool
JNJ
Remicade
Darzalex
Genmab
Multiple Myeloma
Flag link:
Is This Johnson & Johnson's Next Billion-Dollar Blockbuster?
Is This Johnson & Johnson's Next Billion-Dollar Blockbuster?
Motley Fool
JNJ
Darzalex
Multiple Myeloma
Flag link:
3 Biggest Risks for Celgene Corporation
3 Biggest Risks for Celgene Corporation
Motley Fool
Celgene
Darzalex
Multiple Myeloma
Allergan
generics
Abraxane
Revlimid
Flag link:
You'll Never Guess Who Owns the Most Spectacular New Cancer Drug
You'll Never Guess Who Owns the Most Spectacular New Cancer Drug
Motley Fool
JNJ
Darzalex
Multiple Myeloma
Flag link:
Here Are Johnson & Johnson's Next 10 Potential Blockbuster Drugs
Here Are Johnson & Johnson's Next 10 Potential Blockbuster Drugs
Motley Fool
JNJ
Darzalex
sirukumab
guselkumab
imetelstat
Flag link:
This $6.7 Billion Drug Just Keeps Growing
This $6.7 Billion Drug Just Keeps Growing
Motley Fool
JNJ
Darzalex
Celgene
Revlimid
Flag link:
J&J myeloma drug, in combo regimen, delays worsening of the disease
J&J myeloma drug, in combo regimen, delays worsening of the disease
Yahoo/Reuters
JNJ
Multiple Myeloma
Darzalex
Takeda
Velcade
ASCO 2016
Flag link:
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
Flag link:
J&J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies
J&J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies
Fierce Biotech
JNJ
Genentech
Darzalex
atezolizumab
Flag link:
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016
Motley Fool
Big Pharma
JNJ
Novartis
Bristol-Myers Squibb
Darzalex
Entresto
Opdivo
Flag link:
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
Motley Fool
JNJ
FDA
Amgen
Darzalex
daratumumab
Multiple Myeloma
Flag link:
J&J nabs an early OK for 'breakthrough' multiple myeloma blockbuster contender Darzalex
J&J nabs an early OK for 'breakthrough' multiple myeloma blockbuster contender Darzalex
Fierce Biotech
JNJ
Multiple Myeloma
daratumumab
FDA
Darzalex
Genmab
Flag link: